These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1073 related articles for article (PubMed ID: 23558298)
21. Enhanced dual contrast agent, Co(2+)-doped NaYF4:Yb(3+),Tm(3+) nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging. Xia A; Zhang X; Zhang J; Deng Y; Chen Q; Wu S; Huang X; Shen J Biomaterials; 2014 Nov; 35(33):9167-76. PubMed ID: 25108318 [TBL] [Abstract][Full Text] [Related]
22. Conjugation of NaGdF4 upconverting nanoparticles on silica nanospheres as contrast agents for multi-modality imaging. Liu F; He X; Liu L; You H; Zhang H; Wang Z Biomaterials; 2013 Jul; 34(21):5218-25. PubMed ID: 23591393 [TBL] [Abstract][Full Text] [Related]
23. T1-T2 dual-modal MRI of brain gliomas using PEGylated Gd-doped iron oxide nanoparticles. Xiao N; Gu W; Wang H; Deng Y; Shi X; Ye L J Colloid Interface Sci; 2014 Mar; 417():159-65. PubMed ID: 24407672 [TBL] [Abstract][Full Text] [Related]
24. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI. Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680 [TBL] [Abstract][Full Text] [Related]
25. Magnetic/upconversion fluorescent NaGdF4:Yb,Er nanoparticle-based dual-modal molecular probes for imaging tiny tumors in vivo. Liu C; Gao Z; Zeng J; Hou Y; Fang F; Li Y; Qiao R; Shen L; Lei H; Yang W; Gao M ACS Nano; 2013 Aug; 7(8):7227-40. PubMed ID: 23879437 [TBL] [Abstract][Full Text] [Related]
26. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging. Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540 [TBL] [Abstract][Full Text] [Related]
27. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats. Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051 [TBL] [Abstract][Full Text] [Related]
28. High-relaxivity and luminescent silica nanoparticles as multimodal agents for molecular imaging. Lipani E; Laurent S; Surin M; Vander Elst L; Leclère P; Muller RN Langmuir; 2013 Mar; 29(10):3419-27. PubMed ID: 23383648 [TBL] [Abstract][Full Text] [Related]
29. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging. Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995 [TBL] [Abstract][Full Text] [Related]
30. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging. Ju KY; Lee JW; Im GH; Lee S; Pyo J; Park SB; Lee JH; Lee JK Biomacromolecules; 2013 Oct; 14(10):3491-7. PubMed ID: 23987128 [TBL] [Abstract][Full Text] [Related]
31. Gadolinium-chelate nanoparticle entrapped human mesenchymal stem cell via photochemical internalization for cancer diagnosis. Kim KS; Park W; Na K Biomaterials; 2015 Jan; 36():90-7. PubMed ID: 25301637 [TBL] [Abstract][Full Text] [Related]
32. Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging. Watcharin W; Schmithals C; Pleli T; Köberle V; Korkusuz H; Huebner F; Zeuzem S; Korf HW; Vogl TJ; Rittmeyer C; Terfort A; Piiper A; Gelperina S; Kreuter J Eur J Pharm Biopharm; 2014 May; 87(1):132-41. PubMed ID: 24365328 [TBL] [Abstract][Full Text] [Related]
33. Multifunctional nanomesoporous materials with upconversion (in vivo) and downconversion (in vitro) luminescence imaging based on mesoporous capping UCNPs and linking lanthanide complexes. Sun L; Ge X; Liu J; Qiu Y; Wei Z; Tian B; Shi L Nanoscale; 2014 Nov; 6(21):13242-52. PubMed ID: 25263544 [TBL] [Abstract][Full Text] [Related]
34. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550 [TBL] [Abstract][Full Text] [Related]
35. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent. Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017 [TBL] [Abstract][Full Text] [Related]